Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers.

Abstract excerpt

Rare but recurrent mutations in the fibroblast growth factor receptor (FGFR) pathways, most commonly in one of the four FGFR receptor tyrosine kinase genes, can potentially be targeted with broad-spectrum multi-kinase or FGFR selective inhibitors. The complete spectrum of these mutations in paediatric cancers is emerging as precision medicine programs perform comprehensive sequencing of individual tumours....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child
• Share to Fibroblast Growth Factors
• Share to Mutation